406 related articles for article (PubMed ID: 9354427)
61. DNA copy number changes in thyroid carcinoma.
Hemmer S; Wasenius VM; Knuutila S; Franssila K; Joensuu H
Am J Pathol; 1999 May; 154(5):1539-47. PubMed ID: 10329606
[TBL] [Abstract][Full Text] [Related]
62. Cowden syndrome-associated germline SDHD variants alter PTEN nuclear translocation through SRC-induced PTEN oxidation.
Yu W; He X; Ni Y; Ngeow J; Eng C
Hum Mol Genet; 2015 Jan; 24(1):142-53. PubMed ID: 25149476
[TBL] [Abstract][Full Text] [Related]
63. High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas.
Fagin JA; Matsuo K; Karmakar A; Chen DL; Tang SH; Koeffler HP
J Clin Invest; 1993 Jan; 91(1):179-84. PubMed ID: 8423216
[TBL] [Abstract][Full Text] [Related]
64. Mutations in the BRCA2 gene in hepatocellular carcinomas.
Katagiri T; Nakamura Y; Miki Y
Cancer Res; 1996 Oct; 56(20):4575-7. PubMed ID: 8840963
[TBL] [Abstract][Full Text] [Related]
65. Mutations of the adenomatous polyposis coli gene in sporadic thyroid neoplasms.
Zeki K; Spambalg D; Sharifi N; Gonsky R; Fagin JA
J Clin Endocrinol Metab; 1994 Nov; 79(5):1317-21. PubMed ID: 7962323
[TBL] [Abstract][Full Text] [Related]
66. Loss of heterozygosity of the long arm of chromosome 7 in follicular and anaplastic thyroid cancer, but not in papillary thyroid cancer.
Trovato M; Fraggetta F; Villari D; Batolo D; Mackey K; Trimarchi F; Benvenga S
J Clin Endocrinol Metab; 1999 Sep; 84(9):3235-40. PubMed ID: 10487693
[TBL] [Abstract][Full Text] [Related]
67. Characterization of novel non-clonal intrachromosomal rearrangements between the H4 and PTEN genes (H4/PTEN) in human thyroid cell lines and papillary thyroid cancer specimens.
Puxeddu E; Zhao G; Stringer JR; Medvedovic M; Moretti S; Fagin JA
Mutat Res; 2005 Feb; 570(1):17-32. PubMed ID: 15680400
[TBL] [Abstract][Full Text] [Related]
68. Selective occurrence of ras mutations in benign and malignant thyroid follicular neoplasms in Taiwan.
Liu RT; Hou CY; You HL; Huang CC; Hock-Liew ; Chou FF; Wang PW; Cheng JT
Thyroid; 2004 Aug; 14(8):616-21. PubMed ID: 15320975
[TBL] [Abstract][Full Text] [Related]
69. Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers.
Cairns P; Evron E; Okami K; Halachmi N; Esteller M; Herman JG; Bose S; Wang SI; Parsons R; Sidransky D
Oncogene; 1998 Jun; 16(24):3215-8. PubMed ID: 9671402
[TBL] [Abstract][Full Text] [Related]
70. A novel loss-of-function mutation (N48K) in the PTEN gene in a Spanish patient with Cowden disease.
Vega A; Torres J; Torres M; Cameselle-Teijeiro J; Macia M; Carracedo A; Pulido R
J Invest Dermatol; 2003 Dec; 121(6):1356-9. PubMed ID: 14675182
[TBL] [Abstract][Full Text] [Related]
71. PTEN/MMAC1 mutations in hepatocellular carcinomas: somatic inactivation of both alleles in tumors.
Kawamura N; Nagai H; Bando K; Koyama M; Matsumoto S; Tajiri T; Onda M; Fujimoto J; Ueki T; Konishi N; Shiba T; Emi M
Jpn J Cancer Res; 1999 Apr; 90(4):413-8. PubMed ID: 10363579
[TBL] [Abstract][Full Text] [Related]
72. FHIT gene abnormalities in both benign and malignant thyroid tumours.
Zou M; Shi Y; Farid NR; al-Sedairy ST; Paterson MC
Eur J Cancer; 1999 Mar; 35(3):467-72. PubMed ID: 10448301
[TBL] [Abstract][Full Text] [Related]
73. [Cowden disease].
Sawada T; Hamano N; Suzuki A; Okada T; Mabuchi H
Nihon Rinsho; 2000 Jul; 58(7):1479-83. PubMed ID: 10921327
[TBL] [Abstract][Full Text] [Related]
74. Predominant
Lee YA; Im SW; Jung KC; Chung EJ; Shin CH; Kim JI; Park YJ
Thyroid; 2020 Aug; 30(8):1120-1131. PubMed ID: 32228164
[No Abstract] [Full Text] [Related]
75. Loss of heterozygosity in follicular and papillary thyroid carcinomas.
Rodrigues-Serpa A; Catarino A; Soares J
Cancer Genet Cytogenet; 2003 Feb; 141(1):26-31. PubMed ID: 12581895
[TBL] [Abstract][Full Text] [Related]
76. Specific pattern of RAS oncogene mutations in follicular thyroid tumors.
Vasko V; Ferrand M; Di Cristofaro J; Carayon P; Henry JF; de Micco C
J Clin Endocrinol Metab; 2003 Jun; 88(6):2745-52. PubMed ID: 12788883
[TBL] [Abstract][Full Text] [Related]
77. Genetics of Cowden syndrome: through the looking glass of oncology.
Eng C
Int J Oncol; 1998 Mar; 12(3):701-10. PubMed ID: 9472113
[TBL] [Abstract][Full Text] [Related]
78. The familial counterparts of follicular cell--derived thyroid tumors.
Prazeres H; Torres J; Soares P; Sobrinho-Simões M
Int J Surg Pathol; 2010 Aug; 18(4):233-42. PubMed ID: 20444727
[TBL] [Abstract][Full Text] [Related]
79. Two distinct thyroid tumours in a patient with Cowden syndrome carrying both a 10q23 and a mitochondrial DNA germline deletion.
Pradella LM; Zuntini R; Magini P; Ceccarelli C; Neri I; Cerasoli S; Graziano C; Gasparre G; Turchetti D
J Med Genet; 2011 Nov; 48(11):779-82. PubMed ID: 21926107
[TBL] [Abstract][Full Text] [Related]
80. Molecular genetics of thyroid tumors and surgical decision-making.
Learoyd DL; Messina M; Zedenius J; Robinson BG
World J Surg; 2000 Aug; 24(8):923-33. PubMed ID: 10865036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
